Earkart Ltd (EARKART) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Earkart Ltd on NSE and BSE, with an AI summary of each filing.
Earkart Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve Pursuant to Regulation 29(1) of the ....
Intimation · 05 Nov 2026, 5:30 am
Earkart Limited Board Meeting Scheduled for H1 Results and Australian Subsidiary Incorporation Earkart Limited has scheduled a Board of Directors meeting on 5th Nov'26 to consider and approve its unaudited financial results for the half-year ended 30th Sep'26. Additionally, the board will evaluate a proposal to incorporate a wholly-owned subsidiary in Australia. Pursuant to insider trading regulations, the trading window for company insiders remains closed until 7th Nov'26.
To take the approval of Board for Incorporation of Wholly-owned Subsidiary of Earkart Limited
Others (Uncategorized) · 24 Sept 2026, 9:27 pm
Earkart Limited Approves Incorporation of Wholly-Owned Education Subsidiary On 24th Sep'26, Earkart Limited's Board approved the incorporation of a wholly-owned subsidiary, SkillNest Educations Private Limited (or an ROC-approved name), to diversify into the education-related services sector. The company will invest INR 1,00,000 for 100% control, subscribing to 10,000 equity shares at INR 10 each in cash (with 1 nominee share). The new entity will manage, promote, and expand educational institutions and provide operational support services, exploring opportunities outside Earkart’s core hearing-care business subject to ROC approvals.
Intimation of E-voting results and Report of scrutinizer of the 5th Annual General Meeting of the Member of the Earkart Limited
Annual General Meeting · 17 Jul 2026, 9:02 pm
Annual Report for the Financial Year 2025-26 of Earkart Limited
Others (Uncategorized) · 17 Jul 2026, 7:34 pm
Further to our letter dated 23 June 2026 pertaining to date of intimation of 5th Annual General Meeting and pursuant to Regulation 30 of SEBI(Listing Obligations and Disclosure Requirements) ....
Annual General Meeting · 16 Jul 2026, 12:47 am
Pursuant to Regulation 30 of the Securities and Exchange Board of India(''''SEBI'''') (Listing Obligations and Disclosure Requirements) Regulations, 2015, copies of the public notice issued ....
Annual General Meeting · 30 Jun 2026, 4:49 pm
Submission of Investor Presentation for the F.Y. 2026 under Regulation 30 (LODR)
Investor Presentation · 27 Jun 2026, 9:01 pm
Earkart FY26 Investor Presentation Highlights Financials and Growth Strategy Earkart reported FY26 revenue of ₹5,403.53 lakhs, up 25.35% YoY, but PAT declined 28.33% to ₹493.23 lakhs. The EBITDA margin contracted to 15.65% from 22.85% in FY25. Government contracts drove 61.3% of revenue. Key strategic initiatives include scaling its Shop-in-Shop network, expanding government business via GeM and ALIMCO, and global expansion through its new US subsidiary. The company aims to be the largest clinic network by 2027, supported by its patented OMNI remote diagnostic platform.
The 5th Annual General Meeting (AGM) of Earkart Limited (Formerly known as Earkart Private Limited) (''''The Company'''') will be held on Wednesday, 15 July 2026, at 03:00 P.M.(IST) through ....
Annual General Meeting · 23 Jun 2026, 10:58 pm
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing and Disclosure Requirements) Regulations, 2015, as amended ,(''Listing Obligations''), read with para A ....
Others (Uncategorized) · 23 Jun 2026, 4:17 am
Earkart Incorporates New Subsidiary in United Kingdom to Expand Healthcare Services Earkart Limited incorporated a new subsidiary, Earkart Health Limited, in the United Kingdom on 08 Jun'26. Earkart invested GBP 6,500 in cash to acquire a 65% controlling stake, subscribing to 650 equity shares at GBP 10 each. The new entity, part of the healthcare sector, has an authorised and paid-up capital of GBP 10,000. This strategic move is aimed at providing healthcare services and selling related products, aligning with Earkart's core business. The subsidiary is newly formed and has no prior turnover.
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, and read with schedule III of aforesaid regulations dated 30 January ....
Others (Uncategorized) · 30 May 2026, 5:04 pm
Earkart to Incorporate Two Wholly-Owned Subsidiaries Earkart Limited's board, on 29 May'26, approved the incorporation of two wholly-owned subsidiaries (WOS): "Earkart Pharmaceuticals Private Limited" and "Earkart Healthcare Services Private Limited". The company will make a 100% cash subscription to the initial paid-up share capital of Rs. 1,00,000 for each entity at a face value of Rs. 10 per share. The new subsidiaries will enter the pharmaceuticals and healthcare services sectors, respectively, to manufacture, distribute, and provide related services, diversifying the company's business lines.
The statutory auditor of the Company, M/s Timsi & Associates, Chartered Accountants, has issued Audit Report with unmodified opinion on the Audited Fiancial Results of the Company for the ....
Others (Uncategorized) · 29 May 2026, 10:47 pm
Earkart Limited FY26 Audit Report Receives Unmodified Opinion Earkart Limited (BSE: 544549) announced on 29 May'26 that its statutory auditor, M/s Timsi & Associates, has issued an unmodified opinion on the audited financial results for the half-year and full-year ended 31 Mar'26. This declaration, made under SEBI Regulation 33(3)(d), indicates a "clean" audit report with no qualifications or adverse remarks on the company's financial statements. The full report will be available on the company's website.
Audited Standalone Finanical Results for the half year ended and financial year ended 31 March 2026 along with Independent Audit Report issued by M/s Timsi & Associates
Financial Result · 29 May 2026, 10:04 pm
Earkart FY26 Profit Declines 28.3% on Higher Expenses Despite Revenue Growth Earkart reported a 28.3% YoY decline in FY26 net profit to ₹49.32 mn from ₹68.82 mn, driven by a 37.2% surge in total expenses to ₹468.86 mn. This overshadowed a 25.3% YoY revenue growth to ₹540.35 mn for the year ended 31 Mar'26. Basic EPS for FY26 fell to ₹3.99 from ₹6.59 in FY25. For H2 FY26, net profit was ₹30.79 mn on revenue of ₹317.50 mn. The board also appointed new Internal and Secretarial Auditors for FY 2026-27.
The Board of Directors of the Earkart Limited at its meeting held on 29 May 2026 inter alia considered and approved Audited Financial Results for the half year ended and financial year ....
Outcome · 29 May 2026, 9:54 pm
Earkart Ltd - Financial Result for the Quarter ended 31st Mar'26 (Standalone, INR Thousands) ■ Revenue: 3,17,496 (-26.3% YoY | +42.5% QoQ) ■ EBITDA: 52,181 (-46.6% YoY | +66.5% QoQ) ■ EBITDA Margin (%): 16.4 (-621 bps YoY | +237 bps QoQ) ■ PAT: 30,790 (-55.3% YoY | +66.1% QoQ) ■ EPS (INR): 2.49 (-62.2% YoY | +84.4% QoQ)
Earkart Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve 1. To consider and approve the audited ....
Intimation · 29 May 2026, 5:30 am
Earkart Board Meeting Scheduled to Approve Q4 & FY26 Financials Earkart Limited (BSE: 544549) has scheduled a Board of Directors meeting on 29 May'26 to consider and approve the audited financial statements for the quarter and financial year ended 31 Mar'26. The agenda also includes fixing the date for the 5th Annual General Meeting. In relation to this, the trading window for designated persons remains closed until 31 May'26. The window will remain open for general investors. The meeting's outcomes will be a key driver for the stock's near-term performance.
Pursuant to Regulation 30 and Part A of Schedule III of Securities and Exchange Board of India (Listing of Obligations and Disclosure Requirements) Regulation, 2015, we hereby inform you ....
Change in Management · 30 Mar 2026, 10:10 pm
Earkart Appoints Arvind Aggarwal & Associates as Internal Auditor for FY26 Earkart Limited's Board of Directors has approved the appointment of M/s. Arvind Aggarwal & Associates, Chartered Accountants, as the company's Internal Auditor for the financial year 2025-26. The appointment, effective from 30 Mar'26, was made based on the recommendation of the Audit Committee. This move is a key corporate governance update for the company.
Earkart Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/03/2026 ,inter alia, to consider and approve Dear Sir/Madam, Pursuant to Regulation ....
Intimation · 20 Mar 2026, 9:51 pm
Earkart Board to Consider Changes in IPO Proceeds Utilization Earkart Limited (BSE: 544549) has scheduled a Board of Directors meeting on 30th Mar'26. The primary agenda is to consider and approve a variation in the objects and terms for the utilization of its Initial Public Offering (IPO) proceeds. The board will also discuss a potential extension of the time limit for the deployment of these funds. This move suggests a potential pivot or delay in the company's original post-IPO strategic plans, which could impact its growth trajectory and capital allocation.
Pursuant to Regulation 30 and 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') this is to inform ....
Others (Uncategorized) · 11 Mar 2026, 7:17 pm
Earkart Board Approves Land and Pharmaceutical Business Acquisitions Earkart Limited's Board of Directors, in a meeting on 11 Mar'26, approved two key strategic initiatives. The company will proceed with the acquisition of land to establish a new manufacturing facility. Additionally, the board approved the acquisition of an unspecified pharmaceutical business. These decisions signal a potential expansion of the company's manufacturing capabilities and a diversification into the pharmaceutical sector. A subsequent filing clarified the meeting was convened on short notice due to urgent matters.
Acquisition by way of incorporation of a foreign wholly owned subsidiary under the name and style of Earkart Inc. in state of of Delaware.
Others (Uncategorized) · 26 Feb 2026, 10:36 pm
Earkart Incorporates Wholly Owned Subsidiary in Delaware to Expand US Operations Earkart Limited has established a wholly owned subsidiary, "Earkart Inc.," in Delaware, U.S., incorporated on 20th Jan'26. The move is a key step in its United States business expansion strategy. The new entity will focus on scaling a remote audiology and hearing-care platform. Earkart Limited has fully subscribed to 1,000 shares of common stock at a par value of $0.1 per share, representing a 100% shareholding. The transaction is a cash consideration and does not involve related parties.
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, please be informed that Earkart Limited has been awarded a Government Order amounting Rs. 4,12,76,400/- through the Government ....
Others (Uncategorized) · 14 Feb 2026, 9:27 pm
Earkart Secures ₹4.13 Crore Government Supply Contract via GeM Portal Earkart Limited announced on 14th Feb'26 it has won a government order worth ₹4,12,76,400 (₹4.13 crore) through the Government e-Marketplace (GeM). The domestic, one-time supply contract for BTE Hearing Aids was awarded by the Artificial Limbs Manufacturing Corporation of India (ALIMCO). This order is expected to positively contribute to the company's revenue. The transaction does not involve promoter group interest or related parties.
Submission of Transcript of Valueportal Event held on Tuesday January 20, 2026 at 14:00 P.M.
Transcript · 23 Jan 2026, 4:30 pm
Earkart Highlights Growth Strategy and Margin Profile at Investor Event Earkart Limited is targeting India's underserved hearing care market through its patented remote diagnostic and fitting technology, Omni. The company reported a turnover of ₹43 Cr last year and ₹23 Cr in the first half of the current year. Earkart holds a 7-8% market share by units, selling 1.5 lakh aids annually. Gross margins vary by channel: 35-37% for B2G, 40-45% for B2B, and 65-70% for its high-growth B2B2C (SIS) model. Expansion plans include targeting 1,500 clinics over three years and entering US, Australian, and African markets.
Pursuant to Regulation 30 of the SEBI (LODR) Regulations 2015, the Earkart Limited''s Management participated in virtually in an investor interaction titled Valueportal Event organized ....
Audio / Video · 20 Jan 2026, 11:13 pm
Earkart Management Discusses Strategy at Investor Event Earkart Limited management participated in the "Valueportal Event," an investor interaction organized by Finportal Investments on 20th Jan'26. The virtual meeting covered the company's business overview, operational performance, growth strategy, and industry outlook. Discussions were general in nature, with the company confirming that no unpublished price-sensitive information (UPSI) was shared. A recording of the interaction is available on the company's website.
Earkart Limited has successfully bragged a TLM kits order from Govt. amounting Rs. 2.76 Crores
Others (Uncategorized) · 14 Jan 2026, 9:05 pm
Earkart Limited Wins ₹2.76 Crore Government Supply Contract Earkart Limited has secured a domestic supply contract valued at ₹2.76 crore from the Artificial Limbs Manufacturing Corporation of India (ALIMCO). The one-time government order, awarded on 14th Jan '26 via the GeM portal, is for the supply of TLM Kits (LG95). This contract win is expected to positively contribute to the company's revenue. The transaction does not involve promoter group interests or related parties.
Earkart Limited has bragged the order of TLM kits from Govt. amounting Rs. 1.27 Crores
Others (Uncategorized) · 14 Jan 2026, 8:51 pm
Earkart Limited Secures ₹1.27 Crore Government Supply Contract Earkart Limited announced on 14th Jan'26 that it has won a government supply contract valued at ₹1.27 crore. The domestic order, awarded by the Artificial Limbs Manufacturing Corporation of India (ALIMCO) via the Government e-Marketplace (GeM), is for the supply of TLM Kits (LG94). This one-time contract is expected to positively contribute to the company's revenue. The transaction does not involve any promoter group interest or related party transactions.
Earkart Limited will be participating in an investor interaction event titled "Valueportal Event" to be held on Date: 20th January'' 2026 Time: 2:00 P.M. to 3:00 P.M. Mode: Virtual
Others (Uncategorized) · 09 Jan 2026, 9:48 pm
Earkart Limited Announces Participation in Virtual Investor Event on Jan 20 Earkart Limited management will participate in the "Valueportal Event," a virtual investor and analyst interaction organized by Finportal Investments on 20th Jan'26, from 2:00 PM to 3:00 PM. The company confirmed that no unpublished price-sensitive information (UPSI) will be disclosed during the meeting. Key speakers include Promoter & Managing Director Mr. Rohit Misra and Director & CFO Mr. Ajay Kumar Giri. This event provides a platform for investors to engage with the company's leadership and gain insights into its operations.
Outcome enclosed
Outcome · 18 Dec 2025, 6:22 pm
Earkart Board Defers Decision on Turtle Maarks LLP Acquisition Earkart Limited's board discussed the proposed acquisition of Turtle Maarks LLP in its meeting on 18th Dec'25. The Board deferred its decision, authorizing Independent Director Mr. Rajhkumar Jain to conduct a fresh review of valuation and due diligence. A detailed note will be presented at the next board meeting scheduled for 23rd Dec'25, where a final decision on the investment is anticipated. The transaction's financial details remain undisclosed pending this further review.